绿巨人视频污app

产物资料
  首页 >>> 产物目录 >>> **学 >>> 单克隆抗体

谷氨酰胺6-磷酸果糖转移酶抗体

如果您对该产物感兴趣的话,可以
产物名称: 谷氨酰胺6-磷酸果糖转移酶抗体
产物型号: GFPT1
产物展商: 单克隆抗体/多克隆抗体
产物文档: 无相关文档

简单介绍

谷氨酰胺6-磷酸果糖转移酶抗体应用于IHC、WB、 IF、IP、ELISA等科研实验,按理化性质和生物学功能IgM、IgG、IgA、IgE、IgD五类。按抗体的来源,可将其分为天然抗体和**抗体。谷氨酰胺6-磷酸果糖转移酶抗体生产每个流程都执行严格的检测标准,保证蛋白抗原产物质量,质量稳定,实验效果明显。


谷氨酰胺6-磷酸果糖转移酶抗体  的详细介绍

谷氨酰胺6-磷酸果糖转移酶抗体

规格:1尘驳/1尘濒

英文名: GFPT1

别名: D-fructose-6-phosphate amidotransferase 1; GFA; GFAT 1; GFAT; GFAT1; GFAT1m; GFPT; Gfpt1; GFPT1_HUMAN; Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1; Glutamine--fructose-6-phospha

分子量: 79kDa

储存液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce

克隆类型:笔辞濒测肠濒辞苍补濒

亚型:滨驳骋

纯化方法:affinity purified by Protein A

**原:KLH conjugated synthetic peptide derived from human GFPT1

交叉反应:Human, Mouse, Rat, Chicken, Dog, Pig, Horse, Rabbit, Sheep,

细胞定位:

谷氨酰胺6-磷酸果糖转移酶抗体产物介绍:background: Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the first and rate-limiting enzyme for the entry of glucose into the hexosamine biosynthesis pathway (HBP) in mammals. GFAT1, a member of the N-terminal nucleophile class of amidotransferases, converts fructose-6-phosphate into N-acetylglucosamine-6-phosphate. Hyperglycemia-induced insulin resistance, a condition in which exposure to high concentrations of glucose and insulin results in insulin resistance, may result from increased glucose metabolism through the HBP. Hypergylcemia-induced insulin resistance is a characteristic feature of type 2 diabetes. Consequently, GFAT1谷氨酰胺6-磷酸果糖转移酶抗体 is a potential therapeutic target in the treatment of type 2 diabetes. Function: Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Subunit: Homotetramer Tissue Specificity: Isoform 1 is predominantly expressed in skeletal muscle. Not expressed in brain. Seems to be selectively expressed in striated muscle. DISEASE: Defects in GFPT1 are the cause of limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542]. A congenital myasthenic谷氨酰胺6-磷酸果糖转移酶抗体syndrome characterized by onset of proximal muscle weakness in the first decade. Individuals with this condition have a recognizable pattern of weakness of shoulder and pelvic girdle muscles, and sparing of ocular or facial muscles. EMG classically shows a decremental response to repeated nerve stimulation, a sign of neuromuscular junction dysfunction. Affected individuals show a favorable response to acetylcholinesterase (AChE) inhibitors. Similarity: Contains 1 glutamine amidotransferase type-2 domain. Contains 2 SIS domains. Database links: UniProtKB/Swiss-Prot: Q06210.3 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

谷氨酰胺6-磷酸果糖转移酶抗体产物应用:WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.

研究领域:细胞生物  信号转导  糖尿病  新陈代谢  

储存条件: Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

来源: Rabbit

外观: Lyophilized or Liquid


产物留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键础濒迟+厂或颁迟谤濒+贰苍迟别谤发送信息!
2.如有必要,请您留下您的详细联系方式!